Gavea Investimentos’s Pfizer PFE Stock Holding History

Gavea Investimentos’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-160,427	Closed	-$5.59M	–	22
2020 Q3	$5.59M	Buy	+160,427	New	+$5.62M	13.34%	3

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Gavea Investimentos's PFE Position: Q4 2020 in Review

Gavea Investimentos sold out of Pfizer (PFE) in Q4 2020, closing a stake of 160,427 shares — an estimated $5.59M sold.

Gavea Investimentos first reported a position in PFE in Q3 2020 and held it in 1 quarter. The position peaked at $5.59M in Q3 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Gavea Investimentos reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Gavea Investimentos sold 160,427 Pfizer shares in Q4 2020, an estimated $5.59M.
Gavea Investimentos first reported a position in Pfizer in Q3 2020 and held it in 1 quarter.
Gavea Investimentos's Pfizer position peaked at $5.59M in Q3 2020.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Gavea Investimentos's 13F filing for Q4 2020, filed 16 Feb 2021.